Molecular profiles of progesterone receptor loss in human breast tumors. - Wikidata - wikimedia - TriplyDB

Molecular profiles of progesterone receptor loss in human breast tumors.

Molecular profiles of progesterone receptor loss in human breast tumors.

http://www.wikidata.org/entity/Q37083949

about

Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative The biology of progesterone receptor in the normal mammary gland and in breast cancer Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients The molecular profile of luminal B breast cancer Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy.Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors.Finally! A model for progesterone receptor action in normal human breast Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.The rapamycin-regulated gene expression signature determines prognosis for breast cancer.Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications.ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy.A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis.Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expression.Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.Chromatin reprogramming in breast cancer.Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

P2860

Q27016106-0166D307-604E-40A1-B12E-F43DCA9223FF Q30245184-AA9C2066-E9B2-4470-A480-A4EABC37E665 Q33588369-A8054777-1121-431E-83C0-5073601DE29A Q34048140-370FF863-8F5B-4F35-8072-4B3EE5DD27DE Q34783850-04F49A8A-2371-4C63-925A-6BDBDED6425D Q35029548-424FF739-C458-4B82-9D69-746E22C9513B Q35566057-3850D830-9F2F-4715-8081-0F0647B007EB Q35584492-C5A1FF8C-DA01-44C1-9424-2D087F9EE854 Q35868802-524F1462-3E37-4DBB-94FA-09B9E29D3649 Q36038013-4DAC6AAD-8F8D-409B-9A18-58560CE142BF Q36196676-A1349C7E-8C94-41B7-9D91-5E321A9362DC Q36228539-903E33AD-AC4C-413A-A5D5-7797D61840B9 Q37128434-6520A1C6-0D13-4AE9-80D3-662AE242F3D6 Q37208761-648B250D-E5EA-4656-8252-83DEA74E3F69 Q37244577-66585D07-62FC-4C24-B8ED-BF69B09C737D Q37330716-06CC2A03-32E2-453F-A1F5-AF3ABD86BA82 Q37386133-A4AE1E3E-3F53-44FC-A528-32CF30356B10 Q37559006-022FDF03-F397-4B19-9A03-2758174CE783 Q37567005-E325AEB0-1847-44FE-A034-4B05A538A74A Q41498719-C507AFC2-F692-4A31-B87E-E30B89BB1E4C Q42026029-C030E1DE-30BE-4B08-9CC8-FDB0B6804076 Q42373183-2008A2EB-3F8E-4965-A90A-B2D417C257C2 Q43212165-F81A4D4D-4A64-4A6B-9ED8-207F33EED2DC Q43858443-937D4D23-F9D7-48E0-9BBB-8E9D48FF2B44 Q44100959-5486E0ED-D387-476D-84E5-09244EB17B93 Q46398978-99B0D685-E82A-4481-805D-A98C50E62205 Q48030360-07C7E4C5-27AD-49AC-A086-F0A4F1AE3D0B Q52310380-0ABE4554-099C-4C83-B364-1FF4C8884703 Q54468939-A4FBE266-5391-44A4-B6EF-BCD610286A8C Q54480785-968BC1E9-6DB2-4E71-909A-7F55BF02E96E

P2860

Molecular profiles of progesterone receptor loss in human breast tumors.

http://www.wikidata.org/entity/Q37083949

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular profiles of progesterone receptor loss in human breast tumors.

@en

Molecular profiles of progesterone receptor loss in human breast tumors.

@nl

type

label

Molecular profiles of progesterone receptor loss in human breast tumors.

@en

Molecular profiles of progesterone receptor loss in human breast tumors.

@nl

prefLabel

Molecular profiles of progesterone receptor loss in human breast tumors.

@en

Molecular profiles of progesterone receptor loss in human breast tumors.

@nl

P1433

Q37083949-F1728E45-B3B4-47CC-B530-26D4302B4ECE

P1476

Q37083949-311A5A74-C37E-4242-86D9-2906C62894F7

P2093

Q37083949-004ED925-0013-4675-84AC-09A3B241AF09

Q37083949-13074D02-B92B-4B59-BE02-BF64D52CC136

Q37083949-2DA648D7-97AB-4948-ABA6-D870C87F6E17

Q37083949-493E4848-B416-4FC0-A4CD-71AB14B23846

Q37083949-836D837E-3291-494A-BDFD-AAE45788ACE7

Q37083949-8E9E3409-06BC-4950-83BA-D73BDE01323E

Q37083949-AAAE8A5F-F12A-48B2-A8C1-28E3272EBE6B

Q37083949-D6D75E55-044D-4D8F-9344-B06D8253031A

Q37083949-EBD1B403-7155-4C1F-AC7C-9004BFEAB3B5

Q37083949-F8F67BFD-6237-40A8-8D9C-24D5DA4F3D90

P2860

Q37083949-13107C04-8D1B-4406-9D0A-BF06897B3517

Q37083949-140ABFE2-4948-4AB7-9852-B97D2EAB3FE0

Q37083949-180B851A-5847-404E-AD60-10B29E569130

Q37083949-1AA1505A-3D18-422A-AD9D-F1503AD39EC8

Q37083949-2756ABAC-D4B6-4EA2-A9A4-6F686CD23658

Q37083949-2C108E4D-BD07-45DF-853A-E72106856C8C

Q37083949-334056E9-2F0A-41B3-8DBC-14A541291A7B

Q37083949-3543F0C5-BF80-46BD-8A9E-20CEA0D98482

Q37083949-430052FF-140F-4A3C-8197-D3A8C8390428

Q37083949-47A208C5-2AA8-4631-867E-8F3338D7FC12

P2888

Q37083949-0282058A-ADDB-4EC2-8733-7E921E694B28

P304

Q37083949-943E2A94-112F-48BD-8354-B922356F487A

P31

Q37083949-60AC600B-E772-409B-8195-9E04CE38DF62

P356

Q37083949-1C9C9787-5616-4255-ABB0-4907A023A6FB

P407

Q37083949-4A832821-0867-4760-9121-20D7B8CF0B67

P433

Q37083949-59584A7C-6816-498B-89B5-66D81AC96DC0

P478

Q37083949-EF01C4DA-81A2-4ECB-BEB3-D3DDE1F599DA

P50

Q37083949-56F18106-F915-4051-8A77-49C1521C90F3

P577

Q37083949-26454B03-A6B1-4A65-8DF2-6831C67DEB1B

P5875

Q37083949-91A12F34-2E7F-474A-8858-9AD80C553E78

P698

Q37083949-5D9B4BE5-F879-4855-A2D3-60C769E08691

P932

Q37083949-E80A9582-5BB7-4F50-9D70-7475F46C9624

P356

S10549-008-0017-2

P1433

Breast Cancer Research and Treatment

P1476

Molecular profiles of progesterone receptor loss in human breast tumors.

@en

P2093

Adrian V Lee

http://www.w3.org/2001/XMLSchema#string

C Kent Osborne

http://www.w3.org/2001/XMLSchema#string

Chad J Creighton

http://www.w3.org/2001/XMLSchema#string

Dimitry Nuyten

http://www.w3.org/2001/XMLSchema#string

Gary C Chamness

http://www.w3.org/2001/XMLSchema#string

Hugo M Horlings

http://www.w3.org/2001/XMLSchema#string

Jan G Klijn

http://www.w3.org/2001/XMLSchema#string

John A Foekens

http://www.w3.org/2001/XMLSchema#string

Rachel Schiff

http://www.w3.org/2001/XMLSchema#string

Susan G Hilsenbeck

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Java Treeview--extensible visualization of microarray data

P2888

s10549-008-0017-2

P304

287-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-008-0017-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Marc van de Vijver

P577

2008-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5426429

http://www.w3.org/2001/XMLSchema#string

P698

18425577

http://www.w3.org/2001/XMLSchema#string

P932

2635926

http://www.w3.org/2001/XMLSchema#string